Clinical trial NCT05114434 - References

COPD, Chronic Obstructive Pulmonary Disease — Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE)

Citation(s)

•   Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA
  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999 Jul;54(7):581-6.
•   Calzetta L, Cazzola M, Matera MG, Rogliani P
  Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD. Chest. 2019 Apr;155(4):758-770. doi: 10.1016/j.chest.2018.12.016. Epub 2019 Jan 17. Review.
•   Cazzola M, Di Marco F, Santus P, Boveri B, Verga M, Matera MG, Centanni S
  The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD. Pulm Pharmacol Ther. 2004;17(1):35-9.
•   Dal Vecchio L, Polese G, Poggi R, Rossi A
  "Intrinsic" positive end-expiratory pressure in stable patients with chronic obstructive pulmonary disease. Eur Respir J. 1990 Jan;3(1):74-80.
•   Dean J, Panainte C, Khan N, Singh D
  The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD. Respir Res. 2020 Dec 9;21(1):323. doi: 10.1186/s12931-020-01589-5.
•   French CL, Irwin RS, Curley FJ, Krikorian CJ
  Impact of chronic cough on quality of life. Arch Intern Med. 1998 Aug 10-24;158(15):1657-61.
•   Hellebrandová L, Chlumský J, Vostatek P, Novák D, Rýznarová Z, Bunc V
  Airflow limitation is accompanied by diaphragm dysfunction. Physiol Res. 2016 Jul 18;65(3):469-79. Epub 2016 Apr 12.
•   Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N
  Development and first validation of the COPD Assessment Test. Eur Respir J. 2009 Sep;34(3):648-54. doi: 10.1183/09031936.00102509.
•   Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J; Global Initiative for Chronic Obstructive Lung Disease
  Global strategy for the diagnosis, management, and prevention of chron
•   Rogliani P, Matera MG, Facciolo F, Page C, Cazzola M, Calzetta L
  Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo. Br J Pharmacol. 2020 Mar;177(5):115
•   Singh D, Corradi M, Spinola M, Papi A, Usmani OS, Scuri M, Petruzzelli S, Vestbo J
  Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide. Int J Chron Obst
•   Sivasothy P, Brown L, Smith IE, Shneerson JM
  Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness. Thorax
•   Smith JA, Aliverti A, Quaranta M, McGuinness K, Kelsall A, Earis J, Calverley PM
  Chest wall dynamics during voluntary and induced cough in healthy volunteers. J Physiol. 2012 Feb 1;590(3):563-74. doi: 10.1113/jphysiol.2011.213157. Epub 2011 Dec 5.
•   Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R
  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diseas

EFfect of FIxed Triple Beclometasone/Formoterol/Glycopyrronium Therapy on Cough effiCAcy in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) patiEnts: EFFICACE

Details for clinical trial NCT05114434